No evidence that genetic variation in the myeloid-derived suppressor cell pathway influences ovarian cancer survival

Background: The precise mechanism by which the immune system is adversely affected in cancer patients remains poorly understood, but the accumulation of immune suppressive/pro-tumorigenic myeloid-derived suppressor cells (MDSCs) is thought to be one prominent mechanism contributing to immunologic to...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Sucheston-Campbell, Lara E. (VerfasserIn) , Chang-Claude, Jenny (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 2017
In: Cancer epidemiology, biomarkers & prevention
Year: 2016, Jahrgang: 26, Heft: 3, Pages: 420-424
ISSN:1538-7755
DOI:10.1158/1055-9965.EPI-16-0631
Online-Zugang:Verlag, LF, Volltext: http://dx.doi.org/10.1158/1055-9965.EPI-16-0631
Verlag, LF, Volltext: http://cebp.aacrjournals.org/content/early/2016/09/27/1055-9965.EPI-16-0631
Volltext
Verfasserangaben:Lara E. Sucheston-Campbell, Rikki Cannioto, Alyssa I. Clay, John Lewis Etter, Kevin H. Eng, Song Liu, Sebastiano Battaglia, Qiang Hu, J. Brian Szender, Albina Minlikeeva, Janine Joseph, Paul Mayor, Scott I. Abrams, Brahm Segal, Paul K. Wallace, Kah Teong Soh, Emese Z. Zsiros, Hoda Anton-Culver, Elisa V. Bandera, Matthias W. Beckmann, Andrew Berchuck, Line Bjørge, Amanda Bruegl, Ian G. Campbell, Shawn Patrice Campbell, Georgia Chenevix-Trench, Daniel Cramer, Agnieszka Dansonka-Mieszkowska, Fanny Dao, Brenda Diergaarde, Thilo Doerk, Jennifer A. Doherty, Andreas du Bois, Diana Eccles, Svend Aage Engelholm, Peter A. Fasching, Simon A. Gayther, Aleksandra Gentry-Maharaj, Rosalind M. Glasspool, Marc T. Goodman, Jacek Gronwald, Philipp Harter, Alexander Hein, Florian Heitz, Peter Hillemmanns, Claus Hogdall, Estrid V. S. Høgdall, Tomasz Huzarski, Allan Jensen, Sharon E. Johnatty, Audrey Jung, Beth Karlan, Rüdiger Klapdor, Tomasz Kluz, Bozena Konopka, Susanne Krüger Kjær, Jolanta Kupryjanczyk, Diether Lambrechts, Jenny Lester, Jan Lubiński, Douglas A. Levine, Lene Lundvall, Valerie McGuire, Iain A. McNeish, Usha Menon, Francesmary Modugno, Roberta B. Ness, Sandra Orsulic, James Paul, Celeste Leigh Pearce, Tanja Pejovic, Paul Pharoah, Susan J. Ramus, Joseph Rothstein, Mary Anne Rossing, Matthias Rübner, Joellen M. Schildkraut, Barbara Schmalfeldt, Ira Schwaab, Nadeem Siddiqui, Weiva Sieh, Piotr Sobiczewski, Honglin Song, Kathryn L. Terry, Els Van Nieuwenhuysen, Adriaan Vanderstichele, Ignace Vergote, Christine S. Walsh, Penelope M. Webb, Nicolas Wentzensen, Alice S. Whittemore, Anna H. Wu, Argyrios Ziogas, Kunle Odunsi, Jenny Chang-Claude, Ellen L. Goode, and Kirsten B. Moysich

MARC

LEADER 00000caa a2200000 c 4500
001 1576341208
003 DE-627
005 20220814162819.0
007 cr uuu---uuuuu
008 180613r20172016xx |||||o 00| ||eng c
024 7 |a 10.1158/1055-9965.EPI-16-0631  |2 doi 
035 |a (DE-627)1576341208 
035 |a (DE-576)506341208 
035 |a (DE-599)BSZ506341208 
035 |a (OCoLC)1341011592 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Sucheston-Campbell, Lara E.  |e VerfasserIn  |0 (DE-588)1161055568  |0 (DE-627)1024463907  |0 (DE-576)506340651  |4 aut 
245 1 0 |a No evidence that genetic variation in the myeloid-derived suppressor cell pathway influences ovarian cancer survival  |c Lara E. Sucheston-Campbell, Rikki Cannioto, Alyssa I. Clay, John Lewis Etter, Kevin H. Eng, Song Liu, Sebastiano Battaglia, Qiang Hu, J. Brian Szender, Albina Minlikeeva, Janine Joseph, Paul Mayor, Scott I. Abrams, Brahm Segal, Paul K. Wallace, Kah Teong Soh, Emese Z. Zsiros, Hoda Anton-Culver, Elisa V. Bandera, Matthias W. Beckmann, Andrew Berchuck, Line Bjørge, Amanda Bruegl, Ian G. Campbell, Shawn Patrice Campbell, Georgia Chenevix-Trench, Daniel Cramer, Agnieszka Dansonka-Mieszkowska, Fanny Dao, Brenda Diergaarde, Thilo Doerk, Jennifer A. Doherty, Andreas du Bois, Diana Eccles, Svend Aage Engelholm, Peter A. Fasching, Simon A. Gayther, Aleksandra Gentry-Maharaj, Rosalind M. Glasspool, Marc T. Goodman, Jacek Gronwald, Philipp Harter, Alexander Hein, Florian Heitz, Peter Hillemmanns, Claus Hogdall, Estrid V. S. Høgdall, Tomasz Huzarski, Allan Jensen, Sharon E. Johnatty, Audrey Jung, Beth Karlan, Rüdiger Klapdor, Tomasz Kluz, Bozena Konopka, Susanne Krüger Kjær, Jolanta Kupryjanczyk, Diether Lambrechts, Jenny Lester, Jan Lubiński, Douglas A. Levine, Lene Lundvall, Valerie McGuire, Iain A. McNeish, Usha Menon, Francesmary Modugno, Roberta B. Ness, Sandra Orsulic, James Paul, Celeste Leigh Pearce, Tanja Pejovic, Paul Pharoah, Susan J. Ramus, Joseph Rothstein, Mary Anne Rossing, Matthias Rübner, Joellen M. Schildkraut, Barbara Schmalfeldt, Ira Schwaab, Nadeem Siddiqui, Weiva Sieh, Piotr Sobiczewski, Honglin Song, Kathryn L. Terry, Els Van Nieuwenhuysen, Adriaan Vanderstichele, Ignace Vergote, Christine S. Walsh, Penelope M. Webb, Nicolas Wentzensen, Alice S. Whittemore, Anna H. Wu, Argyrios Ziogas, Kunle Odunsi, Jenny Chang-Claude, Ellen L. Goode, and Kirsten B. Moysich 
264 1 |c 2017 
300 |a 5 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Published online first September 27, 2016 
500 |a Gesehen am 13.06.2018 
520 |a Background: The precise mechanism by which the immune system is adversely affected in cancer patients remains poorly understood, but the accumulation of immune suppressive/pro-tumorigenic myeloid-derived suppressor cells (MDSCs) is thought to be one prominent mechanism contributing to immunologic tolerance of malignant cells in epithelial ovarian cancer (EOC). To this end, we hypothesized genetic variation in MDSC pathway genes would be associated with survival after EOC diagnoses. Methods: We measured the hazard of death due to EOC within 10 years of diagnosis, overall and by invasive subtype, attributable to SNPs in 24 genes relevant in the MDSC pathway in 10,751 women diagnosed with invasive EOC. Versatile Gene-based Association study (VEGAS) and the Admixture Likelihood method (AML), were used to test gene and pathway associations with survival. Results: We did not identify individual SNPs that were significantly associated with survival after correction for multiple testing (p<3.5 x 10-5), nor did we identify significant associations between the MDSC pathway overall, or the 24 individual genes and EOC survival. Conclusions: In this well-powered analysis, we observed no evidence that inherited variations in MDSC-associated SNPs, individual genes, or the collective genetic pathway contributed to EOC survival outcomes. Impact: Common inherited variation in genes relevant to MDSCs were not associated with survival in women diagnosed with invasive EOC. 
534 |c 2016 
700 1 |a Chang-Claude, Jenny  |e VerfasserIn  |0 (DE-588)1049304993  |0 (DE-627)781626188  |0 (DE-576)168344475  |4 aut 
773 0 8 |i Enthalten in  |t Cancer epidemiology, biomarkers & prevention  |d Philadelphia, Pa. : AACR, 1991  |g 26(2017), 3, Seite 420-424  |h Online-Ressource  |w (DE-627)325489912  |w (DE-600)2036781-8  |w (DE-576)094752745  |x 1538-7755  |7 nnas  |a No evidence that genetic variation in the myeloid-derived suppressor cell pathway influences ovarian cancer survival 
773 1 8 |g volume:26  |g year:2017  |g number:3  |g pages:420-424  |g extent:5  |a No evidence that genetic variation in the myeloid-derived suppressor cell pathway influences ovarian cancer survival 
856 4 0 |u http://dx.doi.org/10.1158/1055-9965.EPI-16-0631  |x Verlag  |x Resolving-System  |y LF  |3 Volltext 
856 4 0 |u http://cebp.aacrjournals.org/content/early/2016/09/27/1055-9965.EPI-16-0631  |x Verlag  |y LF  |3 Volltext 
951 |a AR 
992 |a 20180613 
993 |a Article 
994 |a 2017 
998 |g 1049304993  |a Chang-Claude, Jenny  |m 1049304993:Chang-Claude, Jenny  |d 50000  |e 50000PC1049304993  |k 0/50000/  |p 95 
999 |a KXP-PPN1576341208  |e 3012629483 
BIB |a Y 
SER |a journal 
JSO |a {"type":{"bibl":"article-journal","media":"Online-Ressource"},"title":[{"title_sort":"No evidence that genetic variation in the myeloid-derived suppressor cell pathway influences ovarian cancer survival","title":"No evidence that genetic variation in the myeloid-derived suppressor cell pathway influences ovarian cancer survival"}],"origin":[{"dateIssuedDisp":"2017","dateIssuedKey":"2017"}],"note":["Published online first September 27, 2016","Gesehen am 13.06.2018"],"id":{"doi":["10.1158/1055-9965.EPI-16-0631"],"eki":["1576341208"]},"physDesc":[{"extent":"5 S."}],"name":{"displayForm":["Lara E. Sucheston-Campbell, Rikki Cannioto, Alyssa I. Clay, John Lewis Etter, Kevin H. Eng, Song Liu, Sebastiano Battaglia, Qiang Hu, J. Brian Szender, Albina Minlikeeva, Janine Joseph, Paul Mayor, Scott I. Abrams, Brahm Segal, Paul K. Wallace, Kah Teong Soh, Emese Z. Zsiros, Hoda Anton-Culver, Elisa V. Bandera, Matthias W. Beckmann, Andrew Berchuck, Line Bjørge, Amanda Bruegl, Ian G. Campbell, Shawn Patrice Campbell, Georgia Chenevix-Trench, Daniel Cramer, Agnieszka Dansonka-Mieszkowska, Fanny Dao, Brenda Diergaarde, Thilo Doerk, Jennifer A. Doherty, Andreas du Bois, Diana Eccles, Svend Aage Engelholm, Peter A. Fasching, Simon A. Gayther, Aleksandra Gentry-Maharaj, Rosalind M. Glasspool, Marc T. Goodman, Jacek Gronwald, Philipp Harter, Alexander Hein, Florian Heitz, Peter Hillemmanns, Claus Hogdall, Estrid V. S. Høgdall, Tomasz Huzarski, Allan Jensen, Sharon E. Johnatty, Audrey Jung, Beth Karlan, Rüdiger Klapdor, Tomasz Kluz, Bozena Konopka, Susanne Krüger Kjær, Jolanta Kupryjanczyk, Diether Lambrechts, Jenny Lester, Jan Lubiński, Douglas A. Levine, Lene Lundvall, Valerie McGuire, Iain A. McNeish, Usha Menon, Francesmary Modugno, Roberta B. Ness, Sandra Orsulic, James Paul, Celeste Leigh Pearce, Tanja Pejovic, Paul Pharoah, Susan J. Ramus, Joseph Rothstein, Mary Anne Rossing, Matthias Rübner, Joellen M. Schildkraut, Barbara Schmalfeldt, Ira Schwaab, Nadeem Siddiqui, Weiva Sieh, Piotr Sobiczewski, Honglin Song, Kathryn L. Terry, Els Van Nieuwenhuysen, Adriaan Vanderstichele, Ignace Vergote, Christine S. Walsh, Penelope M. Webb, Nicolas Wentzensen, Alice S. Whittemore, Anna H. Wu, Argyrios Ziogas, Kunle Odunsi, Jenny Chang-Claude, Ellen L. Goode, and Kirsten B. Moysich"]},"relHost":[{"title":[{"title":"Cancer epidemiology, biomarkers & prevention","title_sort":"Cancer epidemiology, biomarkers & prevention"}],"origin":[{"dateIssuedKey":"1991","publisher":"AACR","dateIssuedDisp":"1991-","publisherPlace":"Philadelphia, Pa."}],"note":["Gesehen am 08.06.2023","Fortsetzung der Druck-Ausgabe"],"pubHistory":["1.1991/92 -"],"disp":"No evidence that genetic variation in the myeloid-derived suppressor cell pathway influences ovarian cancer survivalCancer epidemiology, biomarkers & prevention","type":{"media":"Online-Ressource","bibl":"periodical"},"recId":"325489912","physDesc":[{"extent":"Online-Ressource"}],"name":{"displayForm":["American Association for Cancer Research"]},"id":{"issn":["1538-7755"],"zdb":["2036781-8"],"eki":["325489912"]},"language":["eng"],"part":{"year":"2017","pages":"420-424","issue":"3","text":"26(2017), 3, Seite 420-424","extent":"5","volume":"26"}}],"recId":"1576341208","person":[{"given":"Lara E.","role":"aut","display":"Sucheston-Campbell, Lara E.","family":"Sucheston-Campbell"},{"display":"Chang-Claude, Jenny","family":"Chang-Claude","role":"aut","given":"Jenny"}],"language":["eng"]} 
SRT |a SUCHESTONCNOEVIDENCE2017